Subarachnoid Hemorrhage: An Update.

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Background:

• Subarachnoid hemorrhage (SAH) presents significant morbidity, mortality, and economic burdens.
• High rates of permanent disability impact survivors, necessitating specialized care.
• Current management strategies require refinement to improve patient outcomes.

Purpose of the Study:

• To outline current best practices for managing subarachnoid hemorrhage.
• To emphasize the importance of specialized care at high-volume centers.
• To clarify recommendations regarding fluid management, aneurysm securing, and treatment of delayed cerebral ischemia.

Main Methods:

• Review of current clinical guidelines and evidence-based practices for SAH management.
• Analysis of factors influencing SAH outcomes, including care setting and specific interventions.
• Synthesis of data on the efficacy and risks of various therapeutic approaches.

Main Results:

• Targeting euvolemia, not hypervolemia, is recommended for fluid management.
• Early securing of the aneurysm is critical for preventing rebleeding.
• Statin therapy and magnesium infusions are not indicated for managing delayed cerebral ischemia.
• Cerebral vasospasm is a component of broader delayed cerebral edema.
• Hyponatremia is common post-SAH and linked to longer hospital stays, but not increased mortality.

Conclusions:

• Optimal SAH management involves early intervention and specialized neurocritical care.
• Specific therapeutic interventions, such as statins and magnesium for delayed ischemia, should be avoided.
• Understanding complications like hyponatremia is key to managing patient recovery and hospital length of stay.